Bristol Myers Squibb Shares Bought by FNY Investment Advisers

robot
Abstract generation in progress

FNY Investment Advisers LLC significantly increased its stake in Bristol Myers Squibb Company (NYSE:BMY) during the fourth quarter, purchasing an additional 29,021 shares. This transaction boosts FNY’s total holdings to 31,500 shares, valued at $1.7 million, and indicates growing institutional confidence in Bristol Myers Squibb’s long-term growth prospects due to its robust drug pipeline and strategic acquisitions.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin